The Harvard Crimson9d
Biotech Giant Roche Launches Innovation Center on Harvard’s Allston Research Campus
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...
Business Wire12d
F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Technology Activities, Innovation Programs, Initiatives, Partnership, Investments & Acquisition Network Map ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into ...
F. Hoffmann-La Roche Ltd: Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard's Enterprise Research Campus in Allston
The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and Metabolism, as well as for data science and AI specialists to drive innovation in d ...
Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ...
F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Accelerators, Incubators, and Innovation Programs
The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech activities, ...
Finanznachrichten26d
F. Hoffmann-La Roche Ltd: Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche Global Media Relations Phone: +41 61 688 8888 / e-mail: [email protected] Hans Trees, PhD Phone: +41 79 407 72 58 Sileia Urech Phone: +41 79 935 81 48 ...
Nature4y
Aiming for higher ambition: the Roche approach to cracking the code of cancer
F. Hoffmann-La Roche Ltd, Building 1, Grenzacherstrasse 124, 4070 Basel, Switzerland. Advances in technology are reshaping healthcare, offering many patients the means to track their own health ...
BioWorld23d
Roche describes new NLRP3 inflammasome inhibitors
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have identified NLRP3 inflammasome inhibitors reported to be useful for the treatment of asthma, chronic obstructive pulmonary disease and ...
Nature6y
Obinutuzumab for the treatment of non-Hodgkin lymphomas
F. Hoffmann-La Roche Ltd (Roche) has a rich history of antibody therapies to treat cancers (malignancies) that affect B cells (a type of white blood cell), including non-Hodgkin lymphoma and ...
Yahoo Finance16d
F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Accelerators, Incubators, and Innovation Programs
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering. The report provides ...